Company Filing History:
Years Active: 2022
Title: Elena Czink: Innovator in Tumor Antigen Research
Introduction
Elena Czink is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of medical research, particularly in the development of innovative therapies targeting cancer. Her work focuses on utilizing recombinant viruses to enhance immune responses against tumors.
Latest Patents
Elena Czink holds a patent for a recombinant virus of the family Paramyxoviridae. This invention includes an expressible polynucleotide encoding at least one of a tumor antigen, a fragment of a tumor antigen, or a variant thereof. The patent also encompasses a polynucleotide encoding the recombinant virus and a host cell containing this virus. Furthermore, it details a method for activating immune cells with antitumor activity in samples containing cancer cells, along with various related methods and uses.
Career Highlights
Elena Czink is affiliated with Ruprecht-Karls-Universität Heidelberg, where she conducts her research. Her work has garnered attention for its potential to improve cancer treatment outcomes through innovative approaches.
Collaborations
Elena collaborates with notable colleagues, including Christine Engeland and Guy Ungerechts. These partnerships enhance her research efforts and contribute to the advancement of cancer therapies.
Conclusion
Elena Czink's innovative work in tumor antigen research exemplifies the potential of recombinant viruses in cancer treatment. Her contributions are paving the way for new therapeutic strategies that could significantly impact patient care.